Search

Your search keyword '"Azad, Taha"' showing total 162 results

Search Constraints

Start Over You searched for: Author "Azad, Taha" Remove constraint Author: "Azad, Taha"
162 results on '"Azad, Taha"'

Search Results

2. Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.

3. Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy

4. A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection

5. Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development

7. Rox8 promotes microRNA-dependent yki messenger RNA decay

10. Hydrogen peroxide sensitivity connects the activity of COX5A and NPR3 to the regulation of YAP1 expression

11. Comparative Analysis of Cyclization Techniques in Stapled Peptides: Structural Insights into Protein–Protein Interactions in a SARS-CoV-2 Spike RBD/hACE2 Model System

13. Comparative Analysis of Cyclization Techniques in Stapled Peptides: Structural Insights into Protein–Protein Interactions in a SARS-CoV-2 Spike RBD/hACE2 Model System.

14. Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy

15. Abstract 6417: Deciphering aberrant STING pathway and exploring oncolytic viruses therapy in low grade serous ovarian carcinoma

21. Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment

22. CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX

23. Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer

24. Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen

25. A computational approach to rapidly design peptides that detect SARS-CoV-2 surface protein S

27. Peptides of a Feather: How Computation Is Taking Peptide Therapeutics under Its Wing.

29. Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection

32. Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern

33. Industrial applications of immobilized nano-biocatalysts

36. Luciferase-Based Biosensors in the Era of the COVID-19 Pandemic

37. Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein

41. Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry

44. Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction

45. Characterization of Critical Determinants of ACE2-RBD Interaction

47. Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization

48. Nanoluciferase complementation-based biosensor reveals the importance of N- linked glycosylation of SARS-CoV-2 Spike for viral entry

Catalog

Books, media, physical & digital resources